Mckinley Capital Management LLC Eagle Pharmaceuticals, Inc. Transaction History

Mckinley Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$46.61 - $58.45 $19,809 - $24,841	-425 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$36.72 - $67.73 $15,679 - $28,920	-427 Reduced 50.12%	425 $17,000
Q3 2018 Nov 08, 2018	SELL	$66.65 - $83.86 $4,865 - $6,121	-73 Reduced 7.89%	852 $59,000
Q2 2018 Jul 13, 2018	SELL	$51.25 - $76.62 $3,741 - $5,593	-73 Reduced 7.31%	925 $70,000
Q1 2018 May 04, 2018	SELL	$52.16 - $66.86 $1.53 Million - $1.96 Million	-29,291 Reduced 96.71%	998 $52,000

Q4 2017 Feb 08, 2018	BUY	$49.6 - $60.87 $2,777 - $3,408	56 Added 0.19%	30,289 $1.62 Million
Q3 2017 Nov 13, 2017	BUY	$46.62 - $60.36 $595,244 - $770,676	12,768 Added 73.11%	30,233 $1.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	17,465	17,465 $1.38 Million

10.4M

36.3K

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $71.6M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.